Chronotherapy with low-dose modified-release prednisone for the management of rheumatoid arthritis: a review
Stefano Paolo Beltrametti,1 Aurora Ianniello,2 Clara Ricci3 1Department of Rheumatology, S. Andrea Hospital, Vercelli, 2Rheumatology Outpatient Clinic, Novara, 3Primula Multimedia S.p.A, Pisa, Italy Abstract: To date, rheumatoid arthritis (RA) remains a debilitating, life-threatening disease. One...
Main Authors: | Beltrametti SP, Ianniello A, Ricci C |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-11-01
|
Series: | Therapeutics and Clinical Risk Management |
Subjects: | |
Online Access: | https://www.dovepress.com/chronotherapy-with-low-dose-modified-release-prednisone-for-the-manage-peer-reviewed-article-TCRM |
Similar Items
-
Efficacy and safety of modified-release prednisone in patients with rheumatoid arthritis
by: Krasselt M, et al.
Published: (2016-03-01) -
Low-dose modified-release prednisone in axial spondyloarthritis: 3-month efficacy and tolerability
by: Bandinelli F, et al.
Published: (2016-11-01) -
The efficacy of low dose short-term prednisone therapy for remission induction in newly diagnosed rheumatoid arthritis patients
by: John M. Stacy, et al.
Published: (2021-08-01) -
Patterns of Prednisone Use in Patients with Rheumatoid Arthritis Initiating Treatment with Tocilizumab in Routine US Clinical Practice
by: Dimitrios A. Pappas, et al.
Published: (2019-06-01) -
Balancing the benefits and risks of low-dose glucocorticoid in rheumatoid arthritis.
by: Tânia Santiago, et al.
Published: (2015-01-01)